证券代码：300253 证券简称：卫宁健康 公告编号：2026-014 债券代码：123104 债券简称：卫宁转债 卫宁健康科技集团股份有限公司 2026 年第一次债券持有人会议决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确、完 整，没有虚假记载、误导性陈述或重大遗漏。 7、会议召开的合法、合规性：本次债券持有人会议的召集和召 卫宁健康科技集团股份有限公司（以下简称"公司"）2026 年第 一次债券持有人会议于 2026 年 2 月 9 日在公司会议室召开。会议的 召集、召开与表决程序符合公司《向不特定对象发行可转换公司债券 募集说明书》（以下简称"募集说明书"）、《可转换公司债券持有人 会议规则》的有关规定。 一、会议召开和出席情况 公司 2026 年第一次债券持有人会议通知已于 2026 年 1 月 24 日 以公告形式发出，具体内容详见当日公司于巨潮资讯网刊登的公告。 （一）会议召开情况 1、会议召集人：公司董事会 2、会议召开时间：2026 年 2 月 9 日（星期一）16:00 3、会议召开地点：上海市静安区寿阳路 99 弄 9 号卫宁健康大厦 16 楼会议室 4、会议召开方式：本次会 ...

本公司及董事会全体成员保证信息披露内容的真实、准确、完 整，没有虚假记载、误导性陈述或重大遗漏。 证券代码：300253 证券简称：卫宁健康 公告编号：2026-015 债券代码：123104 债券简称：卫宁转债 卫宁健康科技集团股份有限公司 关于注销回购股份并减少注册资本暨通知债权人的公告 债权人为自然人的，需同时携带有效身份证件的原件及复印件； 委托他人申报的，除前述文件外，还需携带授权委托书和代理人有效 身份证件的原件及复印件。 一、通知债权人的原由 卫宁健康科技集团股份有限公司（以下简称"公司"）于 2026 年 1 月 23 日召开第六届董事会第二十四次会议、2026 年 2 月 9 日召 开 2026 年第一次临时股东会，审议通过了《关于注销回购股份的议 案》，同意注销回购专用证券账户中的股份 14,256,400 股。具体详 见公司于 2026 年 1 月 24 日披露于巨潮资讯网（www.cninfo.com.cn） 的《关于注销回购股份的公告》（公告编号：2026-006）。 公司将向中国证券登记结算有限责任公司深圳分公司申请注销 前述股份 14,256,400 股，本次注销完成后，公司总股 ...

证券代码：300253 证券简称：卫宁健康 公告编号：2026-013 卫宁健康科技集团股份有限公司（以下简称"公司"）董事会于 2026 年 1 月 24 日以公告形式发布了《关于召开 2026 年第一次临时 股东会的通知》，本次股东会以现场投票与网络投票相结合的方式进 行。 现场会议召开时间为：2026 年 2 月 9 日（星期一）14:30；会议 地点为：上海市静安区寿阳路 99 弄 9 号卫宁健康大厦 16 楼会议室； 网络投票时间为：2026 年 2 月 9 日，其中，通过深圳证券交易所交 易系统进行网络投票的具体时间为：2026 年 2 月 9 日 9:15-9:25， 9:30-11:30，13:00-15:00；通过深圳证券交易所互联网投票系统投 票的具体时间为：2026 年 2 月 9 日 9:15-15:00。 卫宁健康科技集团股份有限公司 2026 年第一次临时股东会决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确、完 整，没有虚假记载、误导性陈述或重大遗漏。 特别提示： 1、本次股东会未出现否决议案的情形； 2、本次股东会不涉及变更以往股东会已通过的决议； 3、中小投资者是 ...

Group 1 - The core viewpoint of the news is that Weining Health's stock has seen a significant increase of 5.16%, reaching a price of 11.21 yuan per share, with a trading volume of 660 million yuan and a turnover rate of 3.28%, resulting in a total market capitalization of 24.836 billion yuan [1] - Weining Health Technology Group Co., Ltd. is based in Shanghai and was established on April 7, 2004, with its listing date on August 18, 2011. The company specializes in the research, development, sales, and technical services of medical software, providing comprehensive solutions for the healthcare industry's information technology [1] - The revenue composition of Weining Health includes 84.65% from software and services, 7.89% from hardware sales, and 7.46% from internet healthcare, with no revenue from other sources [1] Group 2 - Among the top ten circulating shareholders of Weining Health, one fund from Nuoan Fund, specifically Nuoan Growth Mixed A (320007), has entered the list in the third quarter, holding 16.891 million shares, which accounts for 0.88% of the circulating shares. The estimated floating profit today is approximately 9.2901 million yuan [2] - Nuoan Growth Mixed A (320007) was established on March 10, 2009, with a current scale of 14.102 billion yuan. Year-to-date returns are 5.36%, ranking 2741 out of 8994 in its category; the one-year return is 34.9%, ranking 2946 out of 8194; and since inception, the return is 200.46% [2]

Group 1 - The core point of the article is that Weining Health Technology Group Co., Ltd. has won a bid for the procurement of the provincial medical insurance imaging cloud system HIS and PACS interface renovation, with a bid amount of 74 million [2][1] - The procurement was conducted by Guizhou University of Traditional Chinese Medicine Second Affiliated Hospital [2][1] - Weining Health has made investments in 52 companies and participated in 10,358 bidding projects [1] Group 2 - Weining Health holds 124 trademark registrations, 522 patents, and 546 copyrights [1] - The company has obtained 24 administrative licenses [1]

Group 1 - The core point of the article is that Weining Health Technology Group Co., Ltd. has won a bid for the interface renovation of the Internet + healthcare support platform for the National Health Medical Big Data Western Center, with a contract amount of 42 million [1][2] - The procurement was conducted by Guizhou University of Traditional Chinese Medicine Second Affiliated Hospital, indicating a significant partnership in the healthcare sector [2] - Weining Health has made investments in 52 companies and participated in 10,358 bidding projects, showcasing its active engagement in the industry [1] Group 2 - The company holds 124 trademark registrations, 522 patents, and 546 copyright registrations, reflecting its strong intellectual property portfolio [1] - Weining Health also possesses 24 administrative licenses, which may enhance its operational capabilities within the healthcare sector [1]

Core Insights - The Tianjin First Central Hospital announced a tender for the "Rehabilitation District Upgrade and Transformation Project Cloud Platform and Core Application Construction Project" with a budget of 66.5 million yuan and a maximum price of 66.218841 million yuan [1][6]. Project Objectives - The project aims to build a core business system for the prevention and control base, based on cloud-native and integrated data lake and data middle platform, supporting features like openness, integration, sharing, and elastic expansion [3][10]. - The system will enhance data sharing and utilization, support scientific research, and improve management and operational efficiency [3][10]. Construction Content - The overall construction is divided into four main parts: cloud infrastructure construction, development of cloud-native software (data middle platform and core business system), network enhancement, and a local disaster recovery plan [5][13]. - The project will leverage the clinical resources of Tianjin First Central Hospital to enhance hospital management, quality control, and decision support through comprehensive information technology upgrades [13]. Bid Results - The bid results announced on February 6, 2026, indicated that Weining Health Technology Group Co., Ltd., in partnership with Tencent Cloud Computing (Beijing) Co., Ltd., won the bid with a price of 65.6 million yuan [6][15]. - The bidding rankings showed that Weining Health ranked first with a score of 95.7728, followed by Tianjin Kaixiang Intelligent Technology Co., Ltd. and China Broadcasting Tianjin Network Co., Ltd. [8][17].

面对多重困境，卫宁健康的破局之路显得尤为艰难。公司需在增强市场信心、优化业务布局和强化内部 治理等方面多管齐下。一方面，高管应减少减持行为，通过增持等方式向市场传递信心；同时，公司需 加强信息披露，及时向投资者解释业绩下滑和管理层变动的原因及应对措施。另一方面，公司应加快新 产品WiNEX的市场推广和收入转化，优化互联网医疗健康业务，减少亏损源，提升整体盈利能力。此 外，公司还需完善治理结构，加强内部控制，避免类似行贿事件再次发生，确保公司运营的合规性和透 明度。 在当前复杂的内外部环境下，卫宁健康能否在困境中找到破局之路，不仅取决于其战略调整和业务优化 的能力，更取决于其能否重塑市场信心和内部治理结构。投资者需密切关注公司的后续动态，谨慎评估 投资风险。 封面图片来源：每日经济新闻 每经评论员 黄胜 2月4日，卫宁健康（SZ300253，股价11.05元，市值244.8亿元）披露董事靳茂的减持结果，套现超1600 万元。此前，去年11月原董事长因单位行贿罪一审获刑后辞职，核心管理层更替，2025年度业绩预告又 由盈转亏。多重压力叠加，让卫宁健康站在了前所未有的十字路口。 高管减持行为在公司业绩与管理层动荡期 ...

"做产品升级时，我们意识到，行业正面临三方面的变革。"孙嘉明表示，一是互联网技术带来了医院形 态的改变，即线上线下的一体化；二是医学范式的改变，基于最新的技术发展，"AI+医生"可望成为未 来医疗范式；三是服务模式的改变，即传统的服务模式将逐渐转换为以患者为中心的服务模式。"因 此，我们致力于打造一款能满足于未来需求的产品。"孙嘉明说。 "有些病人从外院来就诊，会携带大量资料。以往，不同医院间的信息共享是一件比较麻烦的事。"汕头 市人民医院烧伤整形科医生郭绍彬坦言，"仅医院内部，原来也是有病历、检验、影像的3个系统，查看 资料时，就要在它们之间频繁切换。" 郭绍彬告诉记者，纸质报告易磨损，医生手写的记录也难免有辨认误差。他至今记忆深刻，"有一次， 一位患者的既往检查单上的数值模糊，我不得不反复与检验科核对，不仅拖延了诊疗节奏，更让患者产 生了焦虑情绪。" 2019年，具有百余年历史的汕头市人民医院启动数智化建设。数智化系统的引进与持续升级，让上述问 题和隐患得到根本性改善。 党的二十大报告明确提出"推进健康中国建设"。随着新一轮科技革命和产业变革深入推进，大数据、云 计算、区块链、人工智能等数字技术与卫生健康 ...

Group 1 - The company Hekang New Energy has no plans to engage in space photovoltaic business [1] - JinkoSolar stated that it will fulfill information disclosure obligations according to exchange regulations regarding contracts signed in daily operations [1] - Weining Health has not made any investments in brain-computer interface technology [1] Group 2 - Qianli Technology's subsidiary Qianli Zhijia has officially submitted an application for L3-level intelligent driving testing license [1] - Aokang Co. plans to sell part of its silver assets based on market conditions [1] - Changguang Huaxin denied rumors of a 4.5 billion strategic investment from Huawei [1] - Guancheng New Materials reported that the prices of different products for electrolyte additives have increased to varying degrees [1] - Wireless Media confirmed that it does not have any films for the Spring Festival release [1]